SEVERE COMMUNITY-ACQUIRED PNEUMONIA (SCAP)
Clinical trials for SEVERE COMMUNITY-ACQUIRED PNEUMONIA (SCAP) explained in plain language.
Never miss a new study
Get alerted when new SEVERE COMMUNITY-ACQUIRED PNEUMONIA (SCAP) trials appear
Sign up with your email to follow new studies for SEVERE COMMUNITY-ACQUIRED PNEUMONIA (SCAP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can steroids tame deadly pneumonia? new trial aims to find out
Disease control Not yet recruitingThis study tests different doses of steroids for people in the ICU with severe pneumonia caused by adenovirus or Pneumocystis jirovecii. The goal is to see if steroids can reduce the high death rate (25-50%) by calming the body's overactive immune response. About 1,500 adults wil…
Matched conditions: SEVERE COMMUNITY-ACQUIRED PNEUMONIA (SCAP)
Phase: PHASE2, PHASE3 • Sponsor: Qingyuan Zhan • Aim: Disease control
Last updated May 17, 2026 13:59 UTC
-
Global pneumonia study aims to save lives by tracking real-world hospital care
Knowledge-focused Not yet recruitingThis study watches how hospitals around the world treat adults with severe pneumonia that starts outside the hospital. It does not test new drugs or procedures. Researchers will collect information from medical records and follow patients for one year to see what treatments work …
Matched conditions: SEVERE COMMUNITY-ACQUIRED PNEUMONIA (SCAP)
Sponsor: Universidad de la Sabana • Aim: Knowledge-focused
Last updated May 17, 2026 13:57 UTC